triamcinolone acetonide has been researched along with Multiple Sclerosis, Chronic Progressive in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barghorn, S; Eilert, K; Gerlach, B; Haas, T; Lütge, S; Mueller, BK; Mueller, R; Müller, T; Öhm, G; Trommer, I | 1 |
| Abu-Mugheisib, M; Benecke, R; Hoffmann, F; Kamin, F; Koehler, W; Rommer, PS; Winkelmann, A; Zettl, UK | 1 |
| Abu-Mugheisib, M; Benecke, R; Zettl, UK | 1 |
| Brune, N; Hellwig, K; Hoffmann, V; Islamova, S; Lukas, C; Müller, T; Pöhlau, D; Przuntek, H; Schimrigk, S | 1 |
1 review(s) available for triamcinolone acetonide and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration.
Topics: Anti-Inflammatory Agents; Disability Evaluation; Disease Progression; Drug Administration Schedule; Humans; Injections, Spinal; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Triamcinolone Acetonide | 2012 |
2 trial(s) available for triamcinolone acetonide and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Topics: Combined Modality Therapy; Disability Evaluation; Female; Glucocorticoids; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Muscle Spasticity; Quality of Life; Treatment Outcome; Triamcinolone Acetonide; Walking | 2015 |
Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Topics: Adult; Anti-Inflammatory Agents; Cross-Sectional Studies; Disability Evaluation; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Predictive Value of Tests; Severity of Illness Index; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Walking | 2003 |
1 other study(ies) available for triamcinolone acetonide and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Topics: Blotting, Western; Exercise Test; Female; GPI-Linked Proteins; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Nerve Tissue Proteins; Severity of Illness Index; Treatment Outcome; Triamcinolone Acetonide; Walking | 2015 |